Submission of Intimation of Appointment of Director
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Novelix Pharmaceuticals Ltd has appointed Ms. Sridevi Belide (DIN: 10455373) as an Additional Director in the Non-Executive Non-Independent category, effective 23rd October 2025. She is an MBBS-qualified medical professional and will serve on the board until the next Annual General Meeting. Importantly, she is related to the company's Promoters and Promoter Group. The appointment was approved at a board meeting held the same day, which ran from 5:00 PM to 5:30 PM. She is not debarred from holding a directorship by SEBI or any other authority. The filing is signed by Whole-time Director Venkateshwarlu Pulluru.
This is a promoter-family board addition, which strengthens promoter representation and family control over the company's direction. For shareholders, it may raise governance considerations, as the move increases insider/family influence on the board rather than bringing in an truly independent voice.